Overview

Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to compare the antidepressant efficacy and safety of DVS-233 SR versus placebo in adult outpatients with Major Depressive Disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer